Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
WDFC
|
Phenix Q. Kiamilev
VP, GC & Chief Compliance Ofcr |
BUY
Open market or private purchase
|
Indirect | 55 Added 0.0% |
$11,025
$200.46 p/Share
|
Oct 28
2025 |
|
WDFC
|
Steven A Brass
President and CEO |
BUY
Open market or private purchase
|
Direct | 362 Added 1.06% |
$72,566
$200.46 p/Share
|
Oct 28
2025 |
|
WDFC
|
Sara Kathleen Hyzer
VP, Finance & CFO |
BUY
Open market or private purchase
|
Direct | 200 Added 3.26% |
$40,092
$200.46 p/Share
|
Oct 28
2025 |
|
RDN
|
Richard G Thornberry
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 2.18% |
$664,800
$33.24 p/Share
|
Oct 28
2025 |
|
ISRG
|
Myriam Curet
EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 7,562 Reduced 95.54% |
$4,147,227
$548.43 p/Share
|
Oct 28
2025 |
|
ISRG
|
Myriam Curet
EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,562 Added 81.36% |
$1,715,666
$226.88 p/Share
|
Oct 28
2025 |
|
HOWL
|
Ansbert Gadicke |
SELL
Open market or private sale
|
Indirect | 69,068 Reduced 0.0% |
$113,271
$1.64 p/Share
|
Oct 28
2025 |
|
HOWL
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 69,068 Reduced 0.0% |
$113,271
$1.64 p/Share
|
Oct 28
2025 |
|
HOWL
|
Luke Evnin |
SELL
Open market or private sale
|
Indirect | 44,327 Reduced 0.0% |
$72,696
$1.64 p/Share
|
Oct 28
2025 |
|
RFM
|
River North Financial Holdings, LLC |
BUY
Open market or private purchase
|
Direct | 881 Added 6.86% |
$12,607
$14.31 p/Share
|
Oct 28
2025 |
|
CMA
|
James J Herzog
Senior EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 584 Added 1.7% |
$19,254
$32.97 p/Share
|
Oct 28
2025 |
|
CMA
|
James J Herzog
Senior EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 381 Reduced 1.13% |
$29,577
$77.63 p/Share
|
Oct 28
2025 |
|
EBC
|
R David Rosato
Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 10,000 Added 0.0% |
$170,799
$17.08 p/Share
|
Oct 28
2025 |
|
MRP
|
Patrick J Bartels Jr |
BUY
Open market or private purchase
|
Direct | 7,500 Added 19.65% |
$243,900
$32.52 p/Share
|
Oct 28
2025 |
|
PAYIX
|
M Grier Eliasek
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 55,226 Added 27.17% |
$1,399,979
$25.35 p/Share
|
Oct 28
2025 |
|
FLNC
|
Spt Invest Management Sarl |
SELL
Other acquisition or disposition
|
Indirect | 11,761,131 Reduced 0.0% |
-
|
Oct 28
2025 |
|
BY
|
Thomas Abraham
PRESIDENT, SBC |
SELL
Open market or private sale
|
Direct | 23,400 Reduced 37.57% |
$630,162
$26.93 p/Share
|
Oct 28
2025 |
|
UBFO
|
Susan Quigley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,840 Added 6.88% |
-
|
Oct 28
2025 |
|
UBFO
|
Brian Tkacz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,599 Added 8.66% |
-
|
Oct 28
2025 |
|
UBFO
|
Dora Westerlund
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,401 Added 11.34% |
-
|
Oct 28
2025 |
|
UBFO
|
Dennis R Woods
CEO |
BUY
Grant, award, or other acquisition
|
Indirect | 1,308 Added 0.0% |
-
|
Oct 28
2025 |
|
UBFO
|
G Thompson Ellithorpe
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 2,804 Added 0.0% |
-
|
Oct 28
2025 |
|
UBFO
|
Jagroop Gill
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 1,385 Added 0.0% |
-
|
Oct 28
2025 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,250 Added 0.02% |
$363,375
$161.5 p/Share
|
Oct 28
2025 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,250 Reduced 0.02% |
$577,417
$256.63 p/Share
|
Oct 28
2025 |
|
UBFO
|
Heather Hammack
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,551 Added 8.64% |
-
|
Oct 28
2025 |
|
UBFO
|
Nabeel Mahmood
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,333 Added 9.3% |
-
|
Oct 28
2025 |
|
UBFO
|
Kenneth D Newby
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,865 Added 4.57% |
-
|
Oct 28
2025 |
|
MTSI
|
John Kober
Senior VP and CFO |
SELL
Open market or private sale
|
Direct | 1,497 Reduced 3.32% |
$217,903
$145.56 p/Share
|
Oct 28
2025 |
|
PACK
|
Paul Aram
Chief Operating Officer (COO) |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 50.0% |
-
|
Oct 28
2025 |
|
EGP
|
Staci H. Tyler
Executive Vice President, CAO |
SELL
Bona fide gift
|
Direct | 150 Reduced 1.17% |
-
|
Oct 28
2025 |
|
PBF
|
Thomas L O Connor
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 30,353 Added 12.88% |
-
|
Oct 28
2025 |
|
PBF
|
Matthew C. Lucey
CEO & President |
BUY
Grant, award, or other acquisition
|
Direct | 70,372 Added 13.36% |
-
|
Oct 28
2025 |
|
PBF
|
Trecia M Canty
SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 30,353 Added 13.13% |
-
|
Oct 28
2025 |
|
PBF
|
Paul T Davis
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 30,353 Added 13.63% |
-
|
Oct 28
2025 |
|
AGE
|
Randall Moreadith
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 5,551 Reduced 100.0% |
$27,532
$4.96 p/Share
|
Oct 28
2025 |
|
AGE
|
Randall Moreadith
Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,551 Added 50.0% |
$333
$0.06 p/Share
|
Oct 28
2025 |
|
IRDM
|
Robert H Niehaus
Director |
BUY
Open market or private purchase
|
Direct | 30,000 Added 9.16% |
$524,700
$17.49 p/Share
|
Oct 28
2025 |
|
PBF
|
Steven John Andriola
Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct | 6,101 Added 21.69% |
-
|
Oct 28
2025 |
|
IRDM
|
Thomas Fitzpatrick
Director |
SELL
Open market or private sale
|
Direct | 6,797 Reduced 2.63% |
$122,346
$18.0 p/Share
|
Oct 28
2025 |
|
PBF
|
Joseph Daniel Marino
SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 30,353 Added 37.77% |
-
|
Oct 28
2025 |
|
PBF
|
Michael Bukowski
SVP, Head of Refining |
BUY
Grant, award, or other acquisition
|
Direct | 30,353 Added 29.18% |
-
|
Oct 28
2025 |
|
PBF
|
Tai Wendy Ho
Senior Vice President, HR |
BUY
Grant, award, or other acquisition
|
Direct | 30,353 Added 18.14% |
-
|
Oct 28
2025 |
|
PBF
|
James E. Fedena
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 30,353 Added 15.6% |
-
|
Oct 28
2025 |
|
W
|
Niraj Shah
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 17.74% |
$3,165,900
$105.53 p/Share
|
Oct 28
2025 |
|
W
|
Steven Conine
Co-Founder |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 17.74% |
$3,165,900
$105.53 p/Share
|
Oct 28
2025 |
|
UWMC
|
Ishbia Mat
President and CEO |
SELL
Open market or private sale
|
Indirect | 596,356 Reduced 0.0% |
$3,470,791
$5.82 p/Share
|
Oct 28
2025 |
|
PATH
|
Daniel Dines
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.15% |
$772,200
$17.16 p/Share
|
Oct 28
2025 |
|
NUVL
|
Matthew Shair |
SELL
Open market or private sale
|
Direct | 32,455 Reduced 2.29% |
$3,254,262
$100.27 p/Share
|
Oct 28
2025 |
|
NUVL
|
Matthew Shair |
SELL
Open market or private sale
|
Indirect | 9,154 Reduced 0.0% |
$917,871
$100.27 p/Share
|
Oct 28
2025 |